Indefinite Delivery Contract SPE2DX16D2902
- Not listed
- This Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, which runs through December 31, 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders issued under this IDC cover a diverse array of...
- The Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, has awarded a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a performance...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) worth up to $999,999,999 to Amerisourcebergen Drug Corp through December 2026. This single-award IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract covers the delivery of specialty medications, brand-name and generic drugs, vaccines, medical...
- The federal contract IDV award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 with a period of performance through November 2026. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities including specialty...
- The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
- The Defense Logistics Agency (DLA) Troop Support Medical, a defense agency under the Department of Defense, awarded a significant Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as AmerisourceBergen). The IDC has a potential value of up to $999,999,999.00 and a period of performance through December 31, 2025. This contract serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of...
- The Defense Logistics Agency (DLA) has awarded an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to Amerisourcebergen Drug Corp for the delivery of a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of November 30, 2026. As a major pharmaceutical distributor, Amerisourcebergen will leverage its extensive supply chain network to provide a wide array of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
- This federal contract IDV award, with ID SPE2DX15D5002, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs. This single-award IDC serves as the primary vehicle for the DLA to efficiently procure essential medications, specialty drugs, medical devices, and other critical care items from...
The federal contract IDV award SPE2DX16D2902, a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, which runs through December 31, 2025, aims to provide the DLA with a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The IDC serves as the primary vehicle for Amerisourcebergen to efficiently deliver these critical medical commodities to DLA facilities supporting the Department of Defense worldwide through numerous delivery orders. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/2/16 |